Latest webfg news

Hutchmed endometrial cancer treatment gets conditional approval in China	10:04
Hutchmed partner launches Fruzaqla in Japan	22 Nov
Hutchmed to receive $20m Fruzaqla milestone payment	31 Oct
Hutchmed reports positive results from AstraZeneca lung cancer collaboration	16 Oct
Hutchmed partner Takeda gets Japanese approval for Fruzaqla	24 Sep
Hutchmed to present new and updated clinical trial data	09 Sep
Hutchmed withdraws supplemental new drug application in China	30 Aug
Oncology revenue drives first-half growth for Hutchmed	31 Jul
Hutchmed gets tazemetostat new drug application approved in China	04 Jul
Hutchmed partner gets European approval for fruqintinib	24 Jun
Hutchmed publishes positive sovleplenib trial results	17 Jun
Hutchmed China launches two cancer treatment trials	14 May
Hutchmed China to make several presentations at cancer research meeting	05 Apr
Hutchmed endometrial cancer treatment gets priority review in China	02 Apr
Hutchmed cancer treatment indication accepted for review in China	28 Mar
Hutchmed partner Inmagene exercises options over two drug candidates	02 Feb
Hutchmed's 'Elunate' approved under new Hong Kong rules	30 Jan
Hutchmed application for thrombocytopenia treatment accepted in China	11 Jan
Hutchmed completes trial enrolment, keeps drugs on China funding list	13 Dec

Advertising

Gainers

Name	Last	Change	Time
MKS	400.20	3.54%	17:06
EZJ	564.80	3.29%	17:10
RR.	591.40	3.21%	17:12
CNA	130.00	3.01%	16:43
FRES	666.00	2.86%	17:08

Losers

Name	Last	Change	Time
BT.A	156.70	-2.61%	17:10
BATS	2,946.00	-1.80%	17:08
SDR	309.00	-1.78%	16:57
SSE	1,748.00	-1.55%	17:10
STAN	965.80	-1.23%	17:00

Advertising